Partial inhibition of sodium/calcium exchange restores cellular calcium handling in canine heart failure.
about
Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failureThe Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo ExperimentsSERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathwayCa2+ paradox injury mediated through TRPC channels in mouse ventricular myocytes.Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure.Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitroDysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathyFull-length cardiac Na+/Ca2+ exchanger 1 protein is not phosphorylated by protein kinase A.Mitochondrial energetics, pH regulation, and ion dynamics: a computational-experimental approach.Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart.Targeting cardiomyocyte Ca2+ homeostasis in heart failure.Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure.Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signalingBradycardia-mediated ventricular electrical remodeling.Late sodium current in failing heart: friend or foe?Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.Excitation-contraction coupling and mitochondrial energetics.Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.Regulation of the Na+/Ca2+ exchanger by pyridine nucleotide redox potential in ventricular myocytesTargeting calcium handling in arrhythmias.Chronic administration of KB-R7943 induces up-regulation of cardiac NCX1.Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion.The role of Na dysregulation in cardiac disease and how it impacts electrophysiologySodium-calcium exchange inhibitors: therapeutic potential in cardiovascular diseases.Cardiac sodium-calcium exchanger is regulated by allosteric calcium and exchanger inhibitory peptide at distinct sites.Functional alterations after cardiac sodium-calcium exchanger overexpression in heart failure.The ins and outs of calcium in heart failure.The effect of SN-6, a novel sodium-calcium exchange inhibitor, on contractility and calcium handling in isolated failing rat ventricular myocytes.Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.Cardiac effects of SGLT2 inhibitors: the sodium hypothesis.Induced NCX1 overexpression attenuates pressure overload-induced pathological cardiac remodelling.The role of the cardiac Na+/Ca2+ exchanger in reverse remodeling: relevance for LVAD-recovery.Regional genomic regulation of cardiac sodium-calcium exchanger by oestrogen.
P2860
Q26850165-CCD76F33-B35A-48B3-B353-E7DB2DACD037Q28553447-C276B18D-12DD-469B-9DF5-0F9F6B09C756Q28854278-5425C855-1FAC-4268-ABBD-C294BABB7750Q33662444-AF56F1E0-C68E-4FA4-B12F-53153427139EQ33936393-ED31B975-D0D8-4C07-94E3-AA6F47E4272AQ34718320-87B014F4-F7ED-4552-AF0C-80CA28C3D75CQ34725636-077F8C3E-9E33-4745-9571-0AB78B35FF12Q34979295-2F11C1C7-993F-427C-AED6-F9BBB857A622Q35070487-96771C31-4FEB-4D54-BF00-04E0984E5322Q35559287-0D3E437E-1253-4F8C-915D-B70ECAC102DAQ35763705-D8028888-722E-4149-A079-C1875CD004A1Q35851026-DA93402E-91FB-49A9-BF77-3D9629E1D047Q36171335-837007BC-6777-48EB-805D-1FEBBA79FC8BQ36474154-4AA1B641-ED5F-4177-BDA9-10D2AB8565B3Q36496273-04204B7E-0322-45A2-B8B6-CCF617A67DACQ36788875-004887AB-9700-4DAA-9BE9-3C5359A53A23Q36893596-3B4E70B9-9B06-419A-83E1-30C9BCB52A89Q36954069-E4147CBF-7B2A-40E9-B271-51999A934D8FQ37272198-7CA4EA6E-91B6-4F26-82DF-6A9ABAF950B5Q37290746-7B5229E0-0C28-47AA-A3C5-A3C320A63D67Q37447977-180E0415-6D9C-4C3D-B8AB-59572665DC2BQ37656068-FAED9C4F-9839-44EB-9353-1712127AA85EQ39603611-2A06AB8C-24C0-424B-814B-2DCDAE05C51FQ40409849-C79EDE35-C4D6-4D18-8520-1087D4B6A460Q40490233-D8C88F5D-59A3-4962-8092-F3A12602BC78Q42493186-C0CA4056-4AF0-4C99-9575-5D7DF22F87E6Q42549097-15D0FA8F-6C63-4896-94EB-76B8448C6AE4Q44850792-F2CCF82B-0A03-41C1-B658-94CF335D0E05Q48448938-6E1BFD5E-F9C9-45E5-B5ED-4504799AE7D9Q50089120-03E23CBA-5B6C-4B92-BE59-FD36D03ED097Q50849152-73796945-F01C-408A-96F5-20ED14F9EB8CQ51021947-BDD1C5EC-934D-4B53-9322-2A0D2DD1460DQ51518180-13F7807F-8678-40BD-9F15-FCF0C4581493
P2860
Partial inhibition of sodium/calcium exchange restores cellular calcium handling in canine heart failure.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Partial inhibition of sodium/c ...... dling in canine heart failure.
@en
Partial inhibition of sodium/c ...... dling in canine heart failure.
@nl
type
label
Partial inhibition of sodium/c ...... dling in canine heart failure.
@en
Partial inhibition of sodium/c ...... dling in canine heart failure.
@nl
prefLabel
Partial inhibition of sodium/c ...... dling in canine heart failure.
@en
Partial inhibition of sodium/c ...... dling in canine heart failure.
@nl
P2093
P2860
P1433
P1476
Partial inhibition of sodium/c ...... dling in canine heart failure.
@en
P2093
Brian O'Rourke
Christoph Maack
Ion A Hobai
P2860
P304
P356
10.1161/01.RES.0000136817.28691.2D
P577
2004-06-24T00:00:00Z